NCT03491709View on ClinicalTrials.gov

A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC

PHASE1UnknownINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

September 17, 2019

Study Completion Date

December 1, 2019

Conditions
Colorectal Cancer
Interventions
DRUG

anti-EGFR monoclonal antibody

Recombinant anti-EGFR human mouse chimeric monoclonal antibody injection

DRUG

Cetuximab injection

Cetuximab injection

Trial Locations (1)

201203

Shanghai East Hospital Phase 1 Clinical Trial Center, Shanghai

Sponsors
All Listed Sponsors
collaborator

Shanghai East Hospital

OTHER

lead

Dragonboat Biopharmaceutical Company Limited

INDUSTRY